Hypomethylating chemotherapeutic agents as therapy for myelodysplastic syndromes and prevention of acute myeloid leukemia

VG Sorrentino, S Thota, EA Gonzalez, P Rameshwar… - Pharmaceuticals, 2021 - mdpi.com
Myelodysplastic Syndromes (MDSs) affect the elderly and can progress to Acute Myeloid
Leukemia (AML). Epigenetic alterations including DNA methylation and chromatin …

[PDF][PDF] Novel Therapeutic Strategies in Development for Myelodysplastic Syndromes

NAM Hamed - Cancer Therapy & Oncology International Journal, 2019 - researchgate.net
MDS represents a challenge to the hematologists because of the heterogeneous nature of
the disease, and the presence of diversity of conditions across the entire spectrum of MDS …